Compare CLDX & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | RDW |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | 750 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1995 | N/A |
| Metric | CLDX | RDW |
|---|---|---|
| Price | $31.29 | $9.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $44.50 | $13.71 |
| AVG Volume (30 Days) | 882.3K | ★ 12.0M |
| Earning Date | 05-07-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | $41.47 |
| Revenue Next Year | $235.85 | $21.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $14.40 | $4.87 |
| 52 Week High | $31.85 | $22.25 |
| Indicator | CLDX | RDW |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 50.69 |
| Support Level | $24.70 | $7.94 |
| Resistance Level | N/A | $10.23 |
| Average True Range (ATR) | 1.39 | 0.73 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 81.42 | 54.65 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.